Global Parkinson's Genetics Program (GP2) will support the ongoing search for new genetic determinants of Parkinson's disease in diverse populations.

ASAP is committed to making full and immediate open access a reality. The future is science without publication paywalls.

Point of view from ASAP scientific director, Randy Schekman, PhD and managing director, Ekemini A. U. Riley, PhD.